CDOS
Clinical OS
Command
  • Command
Design
  • Studio
  • Biostats
  • Writing
  • EDC
Operate
  • Ops
  • Sites
  • Recruitment
  • Supply
  • Monitoring
  • Patient Portal
Compliance
  • Regulatory
  • Quality
  • Safety
  • Pharmacovigilance
  • TMF
  • Consent
  • Audit
  • Training
  • IRB / Ethics
Business
  • Contracts
  • Finance
  • Meetings
Intelligence
  • Graph
  • Marketplace
  • Integrations
  • CDISC
  • AI Workforce
    14
AI Workforce

8 agents actively monitoring 24 trials.

K
Ask AI
Comply

Safety Management

AE / SAE intake, signal detection, and risk monitoring.

Ask AI Forecast
Open AEs (30d)
184
SAEs requiring reporting
7
Median triage time
1.4h
Active safety signals
3

Adverse events queue

Report new AE
AEPatientTrialTermSeveritySAE
AE-08421PT-2041ONCO-204Grade 2 Neutropenia
Moderate
—Investigate
AE-08418PT-2039ONCO-204Grade 3 Hypertension
Severe
—Investigate
AE-08410PT-2010ONCO-307Pneumonitis
Severe
SAE
Investigate
AE-08402PT-1998RD-118Headache
Mild
—Investigate

Active safety signals

  • ONCO-307 — Pneumonitis cluster (3 cases)
    Recommendation: Convene DSMB this week
    High
  • ONCO-204 — QT prolongation drift (2 sites)
    Recommendation: Add ECG monitoring at C2D1
    Med
  • RD-118 — Liver enzyme elevation outlier
    Recommendation: Continue routine monitoring
    Low

Reporting clock

  • Initial 7-day SUSAR report
    AE-08410
    11h left
  • 15-day follow-up
    AE-08418
    3d left
  • Annual DSUR
    DSUR-118
    42d left
All reporting deadlines tracked against FDA, EMA, PMDA, and MHRA timelines automatically.